EMAIL THIS PAGE TO A FRIEND

Journal of human hypertension

A felodipine-metoprolol extended-release tablet: its properties and clinical development.


PMID 7562899

Abstract

The current failure of antihypertensive therapy to control BP in many hypertensive patients highlights the need for new treatment strategies. Ideally, these new strategies should provide reliable, effective 24 h BP control in all types of patients with a convenient, well-tolerated regimen. Logimax, an extended-release tablet containing felodipine and metoprolol, has been developed, which provides more effective control of BP in a wider range of patients than either component as monotherapy, without compromising tolerability. This combination increases the likelihood of achieving target BP and is therefore likely to provide further reductions in cardiovascular risk.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

F9677
Felodipine, solid
C18H19NO4Cl2
F0030000
Felodipine, European Pharmacopoeia (EP) Reference Standard
C18H19NO4Cl2